DK1152760T3 - Anvendelse af 4-aminopyridin til behandling af perifere neuropatier - Google Patents

Anvendelse af 4-aminopyridin til behandling af perifere neuropatier

Info

Publication number
DK1152760T3
DK1152760T3 DK00911753T DK00911753T DK1152760T3 DK 1152760 T3 DK1152760 T3 DK 1152760T3 DK 00911753 T DK00911753 T DK 00911753T DK 00911753 T DK00911753 T DK 00911753T DK 1152760 T3 DK1152760 T3 DK 1152760T3
Authority
DK
Denmark
Prior art keywords
aminopyridine
treatment
peripheral neuropathies
nervous system
provides methods
Prior art date
Application number
DK00911753T
Other languages
English (en)
Inventor
Jay M Meythaler
Original Assignee
Uab Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uab Research Foundation filed Critical Uab Research Foundation
Application granted granted Critical
Publication of DK1152760T3 publication Critical patent/DK1152760T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
DK00911753T 1999-02-09 2000-02-09 Anvendelse af 4-aminopyridin til behandling af perifere neuropatier DK1152760T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11927399P 1999-02-09 1999-02-09
PCT/US2000/003396 WO2000047210A1 (en) 1999-02-09 2000-02-09 Use of 4-amino pyridine for treatment of peripheral neuropathies

Publications (1)

Publication Number Publication Date
DK1152760T3 true DK1152760T3 (da) 2007-07-30

Family

ID=22383494

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00911753T DK1152760T3 (da) 1999-02-09 2000-02-09 Anvendelse af 4-aminopyridin til behandling af perifere neuropatier

Country Status (10)

Country Link
US (1) US6503931B1 (da)
EP (1) EP1152760B1 (da)
JP (1) JP2002536413A (da)
AT (1) ATE357914T1 (da)
AU (1) AU3360000A (da)
CA (1) CA2360326C (da)
DE (1) DE60034110T2 (da)
DK (1) DK1152760T3 (da)
ES (1) ES2284485T3 (da)
WO (1) WO2000047210A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2820423B1 (fr) * 2001-02-05 2005-12-02 Assist Publ Hopitaux De Paris Tartrate et phosphate de 3,4-diaminopyridine, compositions pharmaceutiques et utilisations
US20050192321A1 (en) * 2003-09-15 2005-09-01 Meythaler Jay M. Treatment of neuropathy with rapid release aminopyridine
US10793893B2 (en) 2011-06-30 2020-10-06 Serb Sa Methods of administering 3,4-diaminopyridine
TWI592156B (zh) * 2011-10-04 2017-07-21 艾可達醫療公司 使用胺基吡啶以治療與中風有關之感覺動作損傷之方法
US9993429B2 (en) 2013-03-15 2018-06-12 University Of Rochester Composition and methods for the treatment of peripheral nerve injury
MA35698B1 (fr) * 2013-05-16 2014-12-01 Univ Mohammed V Souissi Nouvelle composition du 3,4-diaminopyridin pour le traitement de la fatigabilité musculaire associée à des troubles neurovégétatifs.
WO2024011220A1 (en) 2022-07-08 2024-01-11 University Of Rochester Potassium channel blockers or derivatives thereof for preventing, alleviating, and/or treating tissue dysfunction caused by toxic insults

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5221683A (en) * 1984-03-19 1993-06-22 The Rockefeller University Diaminopyridine compounds and methods of use
US4855290A (en) * 1985-05-10 1989-08-08 State Of Israel, Represented By Prime Minister's Office, Israel Institute For Biological Research Derivatives of quinuclidine
IE82916B1 (en) * 1990-11-02 2003-06-11 Elan Corp Plc Formulations and their use in the treatment of neurological diseases
US5668117A (en) * 1991-02-22 1997-09-16 Shapiro; Howard K. Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments
CA2085785C (en) * 1992-12-18 2005-03-15 Robert R. Hansebout The use of 4-aminopyridine in the treatment of a neurological condition

Also Published As

Publication number Publication date
AU3360000A (en) 2000-08-29
US6503931B1 (en) 2003-01-07
CA2360326A1 (en) 2000-08-17
DE60034110T2 (de) 2007-12-06
DE60034110D1 (de) 2007-05-10
EP1152760B1 (en) 2007-03-28
WO2000047210A1 (en) 2000-08-17
EP1152760A1 (en) 2001-11-14
EP1152760A4 (en) 2005-03-23
ATE357914T1 (de) 2007-04-15
CA2360326C (en) 2011-04-05
ES2284485T3 (es) 2007-11-16
JP2002536413A (ja) 2002-10-29

Similar Documents

Publication Publication Date Title
DK0966447T3 (da) Anvendelige små molekyler til behandling af betændelsessygdomme
UA27911C2 (uk) Засіб для лікування або запобігання фізіологічних розладів, які викликані надлишком тахікініну
ATE364386T1 (de) (s,s)-reboxetine zur behandlung von chronischen erschöpfungssyndrom
WO1999054326A8 (de) Dihydropyrimidine
TW200608979A (en) Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
NZ335992A (en) Substituted pyrimidinone and pyridone compounds and methods of use
TR200101859T2 (tr) Kemokin alıcı aktivitesinin modülatörleri olarak N-üreidoalkil-piperidinler
LU91271I2 (fr) Natalizumab et ses dérivés pharmaceutiquement acceptables (TYSABRI)
WO2003080582A3 (de) Fredericamycin-derivate
UA66865C2 (uk) Інденопіролокарбазоли, фармацевтична композиція, спосіб інгібування кіназної активності та спосіб лікування (варіанти)
PT1200412E (pt) Agentes anti-proliferativos de imidazole
AU5624699A (en) Use of 5ht-6 antagonists
NO20052267L (no) Forbindelser, Preparater og Metoder
DK1066056T4 (da) Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernmangel, fremgangsmåde til fremstilling af jerndextranforbindelsen og anvendelse af denne forbindelse til fremstilling af et...
MY141528A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
DK1056454T3 (da) Anvendelse af makrolidforbindelser til behandling af glaukom
UA72948C2 (uk) Заміщені похідні фенілпіперазину, фармацевтична композиція та спосіб лікування афективних або неврологічних захворювань і розладів
TW200640944A (en) VGF polypeptides and methods of treating VGF-related disorders
ES2160410T3 (es) Preparados de complejos de protrombina inmunotolerantes.
DK0846173T3 (da) Anvendelse af et anti-interleukin-9-antistof til fremstilling af et lægemiddel til behandling af astma
DK1152760T3 (da) Anvendelse af 4-aminopyridin til behandling af perifere neuropatier
DK1237562T3 (da) Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme
DK1196442T3 (da) VGF-polypeptider og fremgangsmåder til behandling af VGF-relaterede lidelser
WO1998013009A3 (de) Verwendung von 1-hydroxy-2-pyridonen zur behandlung der seborrhoischen dermatitis
DK1223930T3 (da) Behandling af dyskinesi